Four more rescued after Houthi attack on Greek ship in Red Sea
Four more survivors from the Greek ship Eternity C were rescued from the Red Sea on Thursday, following a deadly Houthi attack that left ten still mis...
Uganda has launched a trial vaccination program for the Sudan strain of Ebola as confirmed cases rise to three. With no approved vaccine for this strain, the trial aims to protect communities and strengthen outbreak response, according to the WHO.
Uganda has launched a trial vaccination program for the strain of Ebola responsible for the country’s latest outbreak, according to the World Health Organization (WHO), as the number of confirmed cases has increased to three.
The East African nation reported an Ebola outbreak in its capital, Kampala, last week, initially identifying a single case—a nurse who passed away on January 29.
Ministry of Health spokesperson Emmanuel Ainebyoona informed Reuters on Monday that the total number of cases has now risen to three, with two additional infections found among the deceased nurse’s family members.
In a post on X later that day, WHO’s Africa director, Matshidiso Moeti, confirmed that Uganda had also initiated a clinical trial for a vaccine targeting the Sudan strain of Ebola.
At present, there is no approved vaccine for this particular strain. The available vaccine is designed to combat the Zaire strain, which has caused a recent outbreak in the neighboring Democratic Republic of Congo.
Bruce Kirenga, head of the Makerere Lung Institute—the research organization conducting the trial—told local media that the vaccine was developed by the International Aids Vaccine Initiative (IAVI), and approximately 2,460 doses had been received for the program.
According to Uganda’s health ministry, the trial is focused on vaccinating individuals who have been in contact with confirmed cases.
Australian researchers have pioneered a low-cost and scalable plasma-based method to produce ammonia gas directly from air, offering a green alternative to the traditional fossil fuel-dependent Haber-Bosch process.
A series of earthquakes have struck Guatemala on Tuesday afternoon, leading authorities to advise residents to evacuate from buildings as a precaution against possible aftershocks.
Archaeologists have uncovered a 3,500-year-old city in northern Peru that likely served as a key trade hub connecting ancient coastal, Andean, and Amazonian cultures.
A deadly mass shooting early on Monday (7 July) in Philadelphia's Grays Ferry neighbourhood left three men dead and nine others wounded, including teenagers, as more than 100 shots were fired.
On July 4, Azerbaijani President Ilham Aliyev met with Turkish President Recep Tayyip Erdoğan in Khankendi, reaffirming the deep-rooted alliance between the two nations.
The European Union is stepping up its health crisis preparedness by stockpiling essential medical supplies and boosting coordination among member states.
New artificial intelligence (AI) software is helping NHS hospitals in Hull reduce MRI scan times, enabling staff to scan more patients each day while improving accessibility for vulnerable groups.
France will impose its toughest outdoor smoking restrictions starting Monday, banning smoking at beaches, parks, playgrounds, and bus stops.
Scientists in Australia and the U.S. have developed an AI tool that could transform cancer care by revealing the hidden diversity of tumour cells and guiding more targeted therapies.
Singapore has launched its largest-ever study on paediatric food allergies, aiming to better understand and address the growing burden of allergic reactions among children.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment